Q1 2026 Holdings
Filed 2026-05-14 | 38 holdings | $248.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Delcath Systems, Inc.(DCTH) | COM NEW | 24661P807 | $30.6M | 3,300,389 | 12.3% |
| Xeris Biopharma Holdings Inc(XERS) | COM | 98422E103 | $18.7M | 3,231,700 | 7.5% |
| Fennec Pharmaceuticals Inc(FENC) | COM | 31447P100 | $17.9M | 2,908,201 | 7.2% |
| Savara Inc(SVRA) | COM | 805111101 | $17.5M | 3,203,721 | 7.0% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $16.9M | 290,000 | 6.8% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $13.4M | 1,036,737 | 5.4% |
| X4 Pharmaceuticals Inc(XFOR) | COM NEW | 98420X202 | $13.3M | 3,214,766 | 5.3% |
| VOR Biopharma Inc(VOR) | COM NEW | 929033207 | $12.5M | 700,000 | 5.0% |
| Mediwound LTD(MDWD) | SHS NEW | M68830112 | $12.1M | 749,054 | 4.8% |
| Verastem Inc(VSTM) | COM NEW | 92337C203 | $11.3M | 2,138,475 | 4.6% |
| Celldex Therapeutics Inc(CLDX) | COM NEW | 15117B202 | $10.5M | 330,000 | 4.2% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $8.8M | 923,057 | 3.5% |
| Cybin Inc(HELP) | COM NEW | 23256X407 | $7.4M | 1,531,814 | 3.0% |
| CG Oncology Inc(CGON) | COM | 156944100 | $6.8M | 100,000 | 2.7% |
| Inspiremd Inc(NSPR) | COM | 45779A846 | $6.4M | 3,905,743 | 2.6% |
| Atea Pharmaceuticals Inc(AVIR) | COM | 04683R106 | $6.3M | 1,171,855 | 2.5% |
| Profound Medical Corp(PROF) | COM NEW | 74319B502 | $5.4M | 828,118 | 2.2% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $4.9M | 250,401 | 2.0% |
| Replimune Group IncCall | CALL | 76029N906 | $2.7M | 1,275,600 | 1.1% |
| Polypid LTD(PYPD) | COM | M8001Q126 | $2.6M | 597,926 | 1.1% |
| Myomo Inc(MYO) | COM NEW | 62857J201 | $2.6M | 3,847,272 | 1.0% |
| Talphera Inc(TLPH) | COM NEW | 00444T209 | $2.5M | 3,353,916 | 1.0% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $2.5M | 1,107,994 | 1.0% |
| Definium Therapeutics Inc(DFTX) | COM SHS | 24477V105 | $2.4M | 125,000 | 0.9% |
| Onkure Therapeutics Inc(OKUR) | COM CL A | 68277Q105 | $1.8M | 443,763 | 0.7% |
| Lipocine Inc(LPCN) | COM NEW | 53630X203 | $1.8M | 221,616 | 0.7% |
| Neuraxis Inc(NRXS) | COM | 64134X201 | $1.7M | 286,138 | 0.7% |
| Avalo Therapeutics Inc(AVTX) | COM NEW | 05338F306 | $1.1M | 75,000 | 0.4% |
| Annexon Inc(ANNX) | COM | 03589W102 | $1.1M | 200,000 | 0.4% |
| Invesco QQQ TRPut | PUT | 46090E953 | $1.1M | 250,000 | 0.4% |
| Aquestive Therapeutics Inc(AQST) | COM | 03843E104 | $1.0M | 250,000 | 0.4% |
| Spdr S&P 500 ETF TRPut | PUT | 78462F953 | $958.5K | 125,000 | 0.4% |
| Biofrontera Inc(BFRI) | COM NEW | 09077D209 | $941.6K | 1,163,962 | 0.4% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $813.0K | 100,000 | 0.3% |
| Regentis Biomaterials LTD | ORDINARY SHARES | M8211G108 | $768.4K | 251,510 | 0.3% |
| Viridian Therapeutics IncPut | PUT | 92790C954 | $52.7K | 263,600 | 0.0% |
| Uniqure NVCall | CALL | N90064901 | $0 | 295,800 | 0.0% |
| Arrivent Biopharma IncCall | CALL | 04272N902 | $0 | 108,900 | 0.0% |